首页> 外文期刊>Diabetes >A Novel Mechanism by Which SDF-1β Protects Cardiac Cells From Palmitate-Induced Endoplasmic Reticulum Stress and Apoptosis via CXCR7 and AMPK/p38 MAPK-Mediated Interleukin-6 Generation
【24h】

A Novel Mechanism by Which SDF-1β Protects Cardiac Cells From Palmitate-Induced Endoplasmic Reticulum Stress and Apoptosis via CXCR7 and AMPK/p38 MAPK-Mediated Interleukin-6 Generation

机译:SDF-1β通过CXCR7和AMPK / p38 MAPK介导的白介素6生成保护心肌细胞免受棕榈酸酯诱导的内质网应激和凋亡的新机制。

获取原文
获取原文并翻译 | 示例
       

摘要

We studied the protective effect of stromal cell-derived factor-1β (SDF-1β) on cardiac cells from lipotoxicity in vitro and diabetes in vivo. Exposure of cardiac cells to palmitate increased apoptosis by activating NADPH oxidase (NOX)-associated nitrosative stress and endoplasmic reticulum (ER) stress, which was abolished by pretreatment with SDF-ip via upregulation of AMP-activated protein kinase (AMPK)-mediated p38 mitogen-activated protein kinase (MAPK) phosphorylation and interleukin-6 (IL-6) production. The SDF-ip cardiac protection could be abolished by inhibition of AMPK, p38 MAPK, or IL-6. Activation of AMPK or addition of recombinant IL-6 recaptured a similar cardiac protection. SDF-ip receptor C-X-C chemokine receptor type 4 (CXCR4) antagonist AMD3100 or CXCR4 small interfering RNA could not, but CXCR7 small interfering RNA completely abolished SDF-1β's protection from palmitate-induced apoptosis and activation of AMPK and p38 MAPK. Administration of SDF-ip to diabetic rats, induced by feeding a high-fat diet, followed by a small dose of streptozotocin, could significantly reduce cardiac apoptosis and increase AMPK phosphorylation along with prevention of diabetes-induced cardiac oxi-dative damage, inflammation, hypertrophy, and remodeling. These results showed that SDF-ip protects against palmitate-induced cardiac apoptosis, which is mediated by NOX-activated nitrosative damage and ER stress, via CXCR7, to activate AMPK/p38 MAPK-mediated IL-6 generation. The cardiac protection by SDF-1β from diabetes-induced oxidative damage, cell death, and remodeling was also associated with AMPK activation.
机译:我们研究了基质细胞衍生因子-1β(SDF-1β)对体外脂毒性和体内糖尿病的心脏细胞的保护作用。通过激活NADPH氧化酶(NOX)相关的亚硝化应激和内质网(ER)应激,使心肌细胞暴露于棕榈酸酯可增加细胞凋亡,而SDF-ip预处理可通过上调AMP激活的蛋白激酶(AMPK)介导的p38来消除这种应激有丝分裂原激活的蛋白激酶(MAPK)磷酸化和白介素6(IL-6)的产生。通过抑制AMPK,p38 MAPK或IL-6可以取消SDF-ip心脏保护。 AMPK的激活或重组IL-6的添加重新获得了类似的心脏保护作用。 SDF-ip受体4型C-X-C趋化因子受体拮抗剂AMD3100或CXCR4小干扰RNA不能,但CXCR7小干扰RNA完全废除了SDF-1β对棕榈酸酯诱导的凋亡以及AMPK和p38 MAPK活化的保护。通过喂食高脂饮食诱导糖尿病大鼠服用SDF-ip,然后再少量服用链脲佐菌素,可以显着减少心脏凋亡并增加AMPK磷酸化,同时预防糖尿病引起的心脏氧化损伤,炎症,肥大,重塑。这些结果表明,SDF-ip通过CXCR7防止棕榈酸酯诱导的心脏凋亡,该凋亡由NOX激活的亚硝化损伤和ER应激介导,从而激活AMPK / p38 MAPK介导的IL-6生成。 SDF-1β对糖尿病引起的氧化损伤,细胞死亡和重塑的心脏保护作用也与AMPK激活有关。

著录项

  • 来源
    《Diabetes》 |2013年第7期|2545-2558|共14页
  • 作者单位

    Cancer Center, the First Hospital of Jilin University, Changchun, China,Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky;

    Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky,Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Wenzhou, China;

    Department of Endocrinology, the First Hospital of Jilin University, Changchun, China;

    Cancer Center, the First Hospital of Jilin University, Changchun, China,Department of Neu-rosurgery, the First Hospital of Jilin University, Changchun, China;

    Cancer Center, the First Hospital of Jilin University, Changchun, China;

    Cancer Center, the First Hospital of Jilin University, Changchun, China;

    Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky,Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Wenzhou, China;

    Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Wenzhou, China;

    Cancer Center, the First Hospital of Jilin University, Changchun, China;

    Cancer Center, the First Hospital of Jilin University, Changchun, China;

    Cancer Center, the First Hospital of Jilin University, Changchun, China,Kosair Children's Hospital Research Institute, Department of Pediatrics, University of Louisville, Louisville, Kentucky,Chinese-American Research Institute for Diabetic Complications, Wenzhou Medical College, Wenzhou, China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:26

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号